Remus Pharmaceuticals filed the quarterly Regulation 76 share capital reconciliation with details on issued/listed capital (1,17,84,000 shares) and Demat status for the quarter ended March 31, 2026.
AI Assistant
Remus Pharmaceuticals Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.